COPD Seven (US, France, Germany, Italy, Spain, UK, Japan) Drug Market Analysis & Forecasts 2024: Sales to Reach $30.8 Billion in 2033 - GSK, AstraZeneca, and Sanofi/Regeneron Compete for First Place
11 oct. 2024 06h35 HE
|
Research and Markets
Dublin, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The "COPD: Seven-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering.This report covers the 7MM (US,...
Respiratory Drugs - Market Insights, Competitive Landscape, and Industry Forecast to 2030; Featuring Company and Product Profiles of AstraZeneca, F. Hoffmann-La Roche, Teva Pharma, Novartis, GSK, and More
29 août 2024 05h37 HE
|
Research and Markets
Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Drugs - Market Insights, Competitive Landscape, and Industry Forecast to 2030" drug pipelines has been added to ResearchAndMarkets.com's...
Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Report 2024: Comprehensive Insights About 65+ Companies and 70+ Pipeline Drugs
17 juil. 2024 09h07 HE
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report...
Cystic Fibrosis (CF) Therapeutics Global Market Research Report 2024: Burgeoning Emphasis on Personalized Medicine and Targeted Therapies - Long-term Forecasts to 2028 and 2033
27 juin 2024 07h40 HE
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis (CF) Therapeutics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The cystic fibrosis (cf)...
Bronchodilator Market to Total US$ 67.8 Billion by 2034 on the Back of Rising Geriatric Population and Growing Prevalence of Respiratory Disease | Future Market Insights Inc.
22 nov. 2023 12h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The global bronchodilator market value is predicted to increase from US$ 38.2 billion in 2024 to US$ 67.8 billion by 2034. Over the forecast period,...
Bronchodilators Global Market Report 2023: Sector to Reach $45 Billion by 2030 at a 4.7% CAGR
15 juin 2023 04h38 HE
|
Research and Markets
Dublin, June 15, 2023 (GLOBE NEWSWIRE) -- The "Bronchodilators - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Bronchodilators Market to Reach...
Global Bronchodilators Market to 2030: Increasing Prevalence of Lung Diseases Drives Growth
06 juin 2023 06h28 HE
|
Research and Markets
Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Bronchodilators Market Size, Share & Trends Analysis Report By Disease (Asthma, COPD), By Route Of Administration (Inhalable, Oral), By Drug Class...
Global Bronchodilators Market to Reach $27 Billion by 2028: Increasing Air Pollution Across the World Drives Growth
17 mars 2023 10h13 HE
|
Research and Markets
Dublin, March 17, 2023 (GLOBE NEWSWIRE) -- The "Global Bronchodilators Market Size, Share & Industry Trends Analysis Report By Drug Class, By Route of Administration, By Disease (Asthma, Chronic...
Nasal delivery devices Market Forecast to 2027: Global COVID-19 Impact and Analysis by Drug Type, Delivery Technologies, End User
24 nov. 2020 02h48 HE
|
Research and Markets
Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "Nasal delivery devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Type; Delivery Technologies; End User, and Geography"...
Luigi Franciosi to Advise on New Asthma & COPD Drug Development Programs for Vicenna Pharmaceuticals Inc.
07 janv. 2020 12h30 HE
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Franciosi Consulting Ltd. (“FCL”) is pleased to announce that its President and CEO, Dr. Luigi Franciosi, has been retained as a...